Dr. Ralph A. Highshaw, MD

Dr. Highshaw practices at Florida Hospital Healthcare Partners, Inc in Ormond Beach, Florida.

Dr. Highshaw's NPI, 1386726453, was assigned on October 19, 2006. Dr. Highshaw graduated from Keck School of Medicine of USC in 1993. Dr. Highshaw holds Florida license ME129129.

Dr. Highshaw's primary practice is Florida Hospital Healthcare Partners, Inc, at 907 Sterthaus Dr, Ormond Beach, FL 32174 in Volusia County. The practice phone is (386) 231-6000.

Dr. Highshaw's primary practice is Florida Hospital Healthcare Partners, Inc in Ormond Beach, Florida. Dr. Highshaw is also affiliated with AdventHealth Daytona Beach. The medical group on file is AdventHealth Medical Group. Dmand AI also links Dr. Highshaw to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Highshaw practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Highshaw's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Highshaw is board certified in urology by the American Board of Urology. Dmand AI has Dr. Highshaw's licenses on file in 6 states: Florida, California, Texas, Illinois, Minnesota and North Dakota.

Dmand AI lists enlarged prostate, enlarged prostate transurethral surgery (TURP), kidney removal surgery, prostate cancer, testicular dysfunction and urinary endoscopy among the conditions Dr. Highshaw treats.

CMS data shows 748 Medicare services from Dr. Highshaw across 14 procedure codes in 2024, for 305 Medicare patients. Medicare paid $90,431 for them.

CMS counts 305 Medicare patients who saw Dr. Highshaw in 2024. The largest group is 65 to 74, with 134 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Highshaw's median patient age at 72, with 22% women.

In 2024, Dr. Highshaw wrote 388 Medicare Part D claims for 168 patients. 99% of them were for generic drugs. CMS names the drug for 314 of them, across 4 drugs with 11 or more claims each, at $3,620 in total drug cost. In 2023, CMS named 25 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Highshaw for performance year 2024, reported as part of a group. Dr. Highshaw accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Highshaw as offering telehealth. CMS counts 21 procedures of prostate resection by Dr. Highshaw, more than 83% of the clinicians it reports for that procedure.

Dmand AI links 9 papers to Dr. Highshaw in 2005. The most frequent topics are Urinary Bladder Neoplasms, Cell Line, Tumor and Neoplasm Invasiveness. Dr. Highshaw's most frequent co-authors are Bogdan A. Czerniak, MD, PhD, Colin P. Dinney, MD and Christopher P. Evans, MD.

CMS Open Payments shows 155 general payments to Dr. Highshaw from 34 drug and device companies from 2016 to 2025. Education make up the largest share, 84% of the total. Intuitive Surgical, Inc. paid the most, $33,026.

Dr. Highshaw graduated from Keck School of Medicine of USC in 1993.

Dr. Highshaw is in network with 13 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.